The National Institute for Pharmaceutical Research Development (NIPRD) and May and Baker Pharmaceutical Company will conclude arrangements on Feb. 23 for the firm to produce and distribute the sickle cell drug, called Niprisan.
The Director-General of the institute, Karniyus Gamaniel, told the News
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
NAN
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
